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Abstract
Purpose—To explore the association between peripapillary atrophy (PPA) area and conversion 
from ocular hypertension (OHT) to glaucoma.
Design—Prospective, longitudinal cohort study of cases and controls.
Participants—Age- and follow-up time-matched 279 eyes with OHT that converted to glaucoma 
and 279 eyes with OHT that did not convert to glaucoma.
Methods—Initial and last acceptable optic disc photos were analyzed. Disc, α- and β-zone PPA 
were traced independently by two trained readers and their areas were measured with Photoshop. 
The α- and β-zone areas were expressed as a percent of optic disc area.
Main Outcome measures—α- and β-zone PPA size over time.
Results—Intraclass correlations (ICC) demonstrated that readers had good agreement on disc 
area (ICC = 0.97) and β-zone (ICC = 0.82), but not α-zone (ICC = 0.48). The ß-zone, as a percent 
of disc area, increased in size (P < 0.001) both in eyes with incident POAG (mean=10.6%, SD = 
22.6%) and matched controls (mean = 10.1%, SD = 33.7), over follow-up (mean = 12.3yrs). The 
increase in size did not differ between cases and controls (P = 0.82). β-zone enlargement was not 
correlated with follow-up time (P = 0.39).
Conclusions—The results did not show a difference in size of β-zone at baseline between eyes 
that proceed to develop glaucoma and those that do not. Moreover, β-zone enlarges equally in case 
and control eyes during follow-up.
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Peripapillary atrophy (PPA) is one of the parameters that are often taken into consideration 
in diagnosing open-angle glaucoma (OAG).1, 2 The association between PPA and OAG has 
been extensively investigated. Although there are a few studies to the contrary,3-5 most 
cross-sectional6-13 and prospective studies14, 15 have found that PPA is more frequent and 
larger in patients with OAG than those without OAG. Other longitudinal studies have 
demonstrated that PPA enlarges in some eyes as glaucoma progresses,7, 15-19 as well in 
some eyes with age.15 It has also been reported that there is a significant association 
between the location of PPA and that of the most marked visual field loss20-22 and that the 
extent of PPA significantly correlates with the degree of optic disc damage and visual field 
defects.20, 23, 24
There have only been a few reports on the prevalence of PPA in patients with ocular 
hypertension (OHT),25, 26 and the issue of whether the presence and/or progression of PPA 
is a risk factor for conversion from OHT to OAG remains uncertain.5, 27-31 However, many 
of these past investigations included relatively small numbers of patients, had poorly defined 
inclusion and exclusion criteria, and were cross-sectional rather than longitudinal. These 
limitations have also made it difficult to make comparisons across studies and highlight the 
need for more data to clarify the association between PPA progression in OHT and 
conversion to glaucoma. Because not all eyes with OHT develop OAG,32-35 it is important 
to identify other factors such as structural changes to the optic disc that may help determine 
the risk of conversion from OHT to glaucoma. Evaluation of a large, prospectively collected 
data on PPA in OHT patients carries the potential to improve our understanding of the 
association of PPA and changes in PPA in OHT with conversion to glaucoma. The Ocular 
Hypertension Treatment Study (OHTS), which has provided the largest data set of 
prospectively collected information on patients with OHT, is well suited to study the 
association of PPA progression in this group of subjects with the onset of glaucoma. The 
OHTS data files contain detailed demographic and clinical information including 
evaluations of serial stereoscopic optic disc photographs taken annually and results of visual 
field testing performed every six months. The present study was designed to assess digitized 
photographs to explore whether PPA enlarges over time during the course of OHT and 
whether enlargement of PPA is associated with conversion to glaucoma.
Materials and Methods
Study Population
The patients enrolled in this study participated in the OHTS, whose protocol has been 
presented elsewhere.35 The institutional review boards at all clinical sites approved their 
respective informed consent statements and procedures. The design of the OHTS followed 
the tenets of the Declaration of Helsinki.36 This OHTS data set files includes information of 
3200 eyes from 1600 subjects studied from February 1994 to December 2009, with over 300 
eyes that converted from OHT to glaucoma through 2008 (personal communication, Mae 
Gordon, OHTS, January 2009). Determination of conversion to POAG in the OHTS was 
defined as the development of a reproducible visual field abnormality and/or a reproducible 
optic disc change consistent with glaucoma in one or both eyes that was attributed to POAG 
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by an endpoint committee masked to randomized treatment assignment. Definitions for 
visual field abnormality and optic disc deterioration are detailed elsewhere.32
This is a nested case-control study. Cases included 279 eyes of 279 participants with OHT 
that converted to POAG and controls were 279 eyes of 222 participants with OHT that did 
not meet conversion criteria in either eye. Case follow-up photographs were those collected 
at the last follow-up study visit. Control follow-up photographs were selected from eyes of 
participants who did not convert to glaucoma and matched with respect to eye laterality, 
participant's age within 5 years, and study follow-up visit within 6 months. Controls and 
cases were matched by the same follow-up visit in all but 2 (1%) matches and by the same 
age (88% of matches), within one year of age (9% of matches), or within 2 to 5 years of age 
(3% of matches).
Optic Disc Slide Scanning and Digitization
Optic disc photographs in the OHTS were acquired at annual visits for both eyes after pupil 
dilation. All images were captured using 35mm film-based technology. The images were 
then mounted in 2-inch × 2-inch slide format, labeled with individual anonymous codes to 
protect confidentiality, and stored at the Optic Disc Reading Center (ODRC) of the OHTS at 
the Bascom Palmer Eye Institute, University of Miami School of Medicine. Standard 35-mm 
Fujifilm 100 ASA (Fuji, Japan) was used for film capture, because of its good image quality. 
Funding from the National Eye Institute supported the creation of a digital archive of all 
stereoscopic disc photographs collected during the OHTS. All original photographic 
transparencies of all subjects’ visits were then digitized in RGB format using a Nikon Super 
CoolScan 5000ED scanner with SilverFast Ai software (LaserSoft Imaging Inc., Sarasota, 
Florida, USA) and saved in Tagged Image File Format (TIFF). If the disc photos were taken 
with a sequential fundus camera, left and right images were scanned individually, cropped 
with Adobe Photoshop 3.0 (Adobe System, Inc., Mountain View, CA), placed side-by-side, 
and then saved as a single image of the stereoscopic pair. Disc photos taken with a 
simultaneous fundus camera were scanned and saved with no image manipulation. All 
images were labeled after the scanning process and moved to server storage.
Scanned Optic Disc Image Evaluation and PPA Margin Delineation
The baseline and study follow-up visit digital stereoscopic optic disc photographs of eyes 
with glaucoma and matched controls were retrieved from the server and presented on an 
interactive battery-free pen and liquid crystal display unit (WACOM Cintiq 12WX, 
Vancouver, WA) for evaluation. Stereoscopic disc photographs with poor image quality (for 
example, due to cataract or technical reasons) that prevented reliable outlining of the disc 
margin or the boundaries of the peripapillary zones α and β37 were excluded and replaced by 
the one taken immediately after (if a baseline photograph) or immediately before (if a 
follow-up photograph). Each stereoscopic photograph was evaluated independently by two 
readers (ES, RV) from the ODRC of the OHTS using a hand-held stereoscope (Screen-VU, 
Portland, OR) to view the images stereoscopically on the liquid crystal display. The ODRC 
readers underwent extensive training in identification of optic disc structures and tracing by 
a senior investigator (DRA).
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The drawing tool (pen) was calibrated before each tracing session and standardized in terms 
of tip size (in pixels) and hardness. The structures to be quantified (optic disc, peripapillary 
zones α and β areas) were outlined on the inside edge so that the thickness of the trace 
would be incorporated in the total delineated area. Images were evaluated in a masked 
fashion without knowledge of the clinical diagnosis or other clinical information.
The border of the optic disc was defined as the inner margin of the peripapillary scleral ring 
of Elschnig, recognized as a white band seen in part of or all around the circumference of 
the optic disc, or by the boundary between disc tissue and retinal pigment epithelium when it 
obscured the scleral ring. PPA was differentiated into α- and β-zones as described by Jonas 
et al.37 Alpha-zone was defined as an irregular area of hypopigmentation and 
hyperpigmentation adjacent to the scleral ring or located on the outer side of β-zone if 
present. Beta-zone, when present, extended from the scleral ring and was characterized by 
the absent retinal pigment epithelium, making visible the sclera or the choroid with its large 
vessels. The peripapillary scleral ring was included in the measurements of β-zone (Figure 
1). Because the width of the scleral ring was usually very thin, any error introduced by 
adding the scleral ring area to β-zone was considered to be inconsequential. For each 
stereoscopic image, readers outlined successively three concentric regions: the edge of the 
optic disc, the area occupied by the optic disc and PPA β-zone, and finally the region 
including optic disc and PPA β- and α-zones on the right side of the stereo pair, unless the 
left side provided a better quality image.
Planimetric Analysis
Measuring tools of Adobe Photoshop were used to generate the areas automatically, in 
pixels, on an outlined image. For each disc image, the software calculated the areas 
corresponding to disc area, along the inner edge of the scleral ring, if visible, a second area 
that included the optic disc with any visible scleral rim and the β-zone (if present), and a 
third area that included the previous plus the α-zone (if present).
The α- and β-zone areas (obtained by subtraction of the three traced outlines) were 
normalized to the optic disc area by expressing it as a percent of the disc area to minimize 
the effects of the difference in camera magnification and/or refraction-related errors.
Statistical Analysis
Paired t-tests were used to compare the spherical equivalent, optic disc area in pixels and 
peripapillary atrophy areas in pixels and in percent of optic disc. Participant age was 
compared with t-test and gender was compared with chi-square test. The intraclass 
correlation coefficient (ICC) was used to assess between reader agreement for disc, β- and 
α-zones areas in pixels and β- and α-zones as a percent of optic disc area. In an ancillary 
analysis, generalized estimating equations with exchangeable covariance structure and 
robust estimates were used to account for use of the contralateral eye as a control in more 
than one matched pair in the comparison of follow up minus baseline zone areas as a percent 
of disc areas. A p-value of 0.05 or less was considered statistically significant.
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Characteristics of the case and control groups at the baseline visit are summarized in Table 
1. Mean age was identical due to study design. Mean spherical equivalent was also 
comparable between the two groups (paired t-test). None of the eyes in the two groups had a 
spherical equivalent refractive error more myopic than -9D. Sixteen (5.7%) converted by 
both optic disc and visual field; 153 (54.8%) converted by optic disc criteria first, and 
sixteen (39.4%) of the 279 cases converted by visual field criteria first.
Reproducibility of Measurements
Intra-class correlation coefficient (ICC) was used to assess between reader agreement for 
disc, β- and α-zones areas in pixels and β- and α-zones as a percent of optic disc area. Table 
2 presents the between reader reproducibility of baseline and follow-up optic disc, PPA β- 
and α-zone area measurements for cases and controls based on all images measured. 
Agreement was assessed before conversion from pixels to percent of disc area to assess of 
reproducibility of disc measurements and to ensure that the conversion had not adversely 
impacted reproducibility of overall measurements. The scale of agreement strength as 
proposed by Fleiss is as follows: values greater than 0.75 represent excellent agreement 
beyond chance, values between 0.40 and 0.75 represent fair to moderate agreement, and 
values below 0.40 represent poor agreement.38 Between reader ICCs were excellent for both 
baseline and follow-up PPA β-zone measurements and moderate for PPA α-zone 
measurements. In this study, ICC of between reader PPA change over time as a percent of 
disc area were 0.72 (95% CI: 0.67 – 0.75) for β-zone, considered good reproducibility; and 
0.51 (95% CI: 0.45 – 0.57) for α-zone, considered fair to moderate. Examination of Bland-
Altman plots revealed no systematic differences between readers with respect to size of PPA 
changes (Figure 2).
Baseline PPA Measurements as a Percent of Disc Area
Baseline β-zone areas averaged 49.9% (SD: 24.3%, range: 20.1 – 143.6%) in cases and 
47.4% (SD: 20.3%, range: 19.2 – 246.6%) in controls (p=0.18, paired t-test). Baseline α-
zone areas averaged 19.1% (SD: 21.0%, range: 0 – 101.1%) in cases and 20.4% (SD: 15.8%, 
range: 0 – 275.3%) in controls (p=0.41, paired t-test). At baseline, 24 (9%) of cases and 22 
(8%) of controls had no measurable α-zone, which did not differ significantly between the 
groups (p=0.88, McNemar's test, data not shown in the Table). Beta-zone was present in all 
cases and controls, except in one control eye, because Elschnig's scleral ring was 
incorporated to β-zone measurements. Thus, the β-zone measurements, when small, 
represent measurements of the scleral rim area only without any true β-zone in which retinal 
pigment epithelium did not completely cover peripapillary choroid. We did not attempt to 
distinguish these two anatomic structures, as the scleral rim is small and does not disrupt 
calculations of any β-zone increase with time.
PPA Change over Time as a Percent of Disc Area
The study follow-up visit at which disc photos used in this analysis were collected ranged 
from 12 to 168 months, with median of 156 months. The 10th and 90th percentiles were 120 
and 162 months, respectively, so most follow-up times were within a 3.5 year range of each 
Savatovsky et al. Page 5













other, from 10 to 13.5 years. Over this time, β-zone increased by 10% in both cases that 
converted to OAG (p < 0.001, paired t-test) and unconverted controls (P < 0.001, paired t-
test) (Table 3). Change in β-zone area (follow-up minus baseline) in cases and controls were 
not statistically different (P = 0.82, paired t-test) (Figure 3). ). The p-value was similar when 
generalized estimating equations were used in an ancillary analysis (P = 0.87). There was a 
highly statistically significant difference (P < 0.001) in mean α-zone areas expressed as a 
percent of disc area between the two groups (Table 3). There was similarly a statistically 
significant difference between the mean change of α-zone from baseline to follow-up (3.9% 
difference P = 0.021, paired t-test). An ancillary analysis using generalized estimating 
equations produced a similar result (P = 0.018). However, this difference included a small 
increase in cases and an apparent small reduction of α-zone area in the non-converting 
controls. The range of the differences was from −60.0% to +242.0% (SD of 27.9% around 
the mean change of 3.9%), so with such an overlap, the small mean change cannot be 
considered of much importance. Analysis of the combined α- and β-zones change over 
follow-up also failed to show differences between converters to OAG and non-converter 
controls (P = 0.1, paired t-test).
Cases that converted by disc criteria (with or without visual field conversion) averaged an 
11.5 ± 23.6% β-zone enlargement as a percent of the disc area as opposed to 7.1 ± 18.5% β-
zone enlargement in controls; the difference was not statistically significant (P = 0.17, t-test; 
P = 0.18 ANCOVA accounting for months of follow-up). Whether conversion was by disc 
or visual field criteria also did not influence the difference in β-zone enlargement rate in 
cases versus controls (P = 0.19, repeated measures ANOVA test of case/control status with 
evaluation for potential interaction between β-zone enlargement and study protocol 
determination of conversion by disc or field criteria). In cases, β-zone enlargement from 
baseline to last follow-up did not correlate with the time interval (range: 0 to 156 months) 
from determination of endpoint to the date at which the follow-up disc photograph was 
obtained (Pearson r = −0.04, P = 0.57).
Discussion
Because of the uncertainty of the relationship between PPA and the development of 
glaucoma, the opportunity for a longitudinal study with large number of subjects was the 
impetus for designing the present study. Although PPA has been associated with glaucoma 
in cross-sectional studies, it is unknown whether PPA or its worsening precedes the 
development of primary open angle glaucoma, coincident with it, or unrelated in time. In 
addition, the issue of whether PPA is larger in OHT eyes that subsequently convert to 
glaucoma compared to PPA in non-converting eyes has been suggested,25 but not 
definitively explored. Determining whether PPA size at baseline is associated with a higher 
risk of later conversion of OHT to OAG is of clinical importance, as it may allow closer 
monitoring or earlier treatment of OHT patients who are deemed to be at risk. Alternatively, 
PPA may enlarge in concert with development and progression of glaucomatous cupping, 
which is of interest in understanding the pathogenesis of each. The OHTS data set is well 
suited for the study of these questions, because of a large overall sample size, long-term 
prospective follow-up, and rigorous criteria for POAG endpoints.
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We found that both at baseline and follow-up, the ICCs were excellent for PPA β-zone and 
moderate for α-zone measurements in these eyes matched and paired with each other. There 
was no significant difference between cases and controls in baseline or follow-up of either 
the PPA β-zone or α-zone. The magnitude of change in β-zone area over time was similar in 
cases and controls. In contrast, the change in α-zone area was statistically significantly, 
different between the two groups, but small and highly variable. To see whether there was 
evidence that β-zone enlargement occurred after conversion to glaucoma, we also assessed 
the strength of correlation between β-zone enlargement and months between conversion and 
last follow up in the cases. No correlation was found. Possibly abnormal IOP and a large β-
zone each represent a risk factor, but in combination with other causative risk factors in a 
quantified manner not yet known, but none of which are necessary if other factors dominate.
Determination of optic disc borders is somewhat subjective, which potentially, brings a 
certain degree of variability into the measurements. Yet, we found excellent between reader 
agreements for both PPA zones, which implies that measurement variability did not impact 
our results. Tuulonen et al39 evaluated the variability of baseline PPA measurements (in 
mm2) in 23 eyes of 23 OAG patients and age-matched controls obtained by manual 
planimetry and reported between-observer Pearson correlation values of 0.97 for optic disc 
area, 0.91 for β-zone area, and 0.63 for α-zone area. The reported agreement is comparable 
to the current study.
Unlike some previous studies, we chose to estimate α- and β-zone measurements as percent 
of optic disc area rather than absolute areas because optic disc photographs were taken with 
different cameras having different magnifications, and because the clinical parameters 
needed to calculate the absolute areas were not available. Nevertheless, assuming disc area 
to be constant over time, a change in the PPA (α- or β-zones) area-to-disc ratio should be 
related to the change in PPA area. Alpha zones are more difficult to delineate than β-zone 
ones (especially with media changes over time) and changes are consequently quite variable 
within each of the study groups. The ICC is only moderate, and the smaller, but statistically 
significant, reduction in the non-converter controls (Table 3) is difficult to interpret.
Enlargement of PPA, in particular β-zone, has been correlated with progressive 
glaucomatous damage in several studies with various methodology. Rockwood and 
Anderson15 in a retrospective optic disc stereophotograph review, found qualitatively 
noticeable increase in PPA size as a whole in 21% of eyes with progressive glaucoma versus 
4% of eyes with non-progressive glaucoma and eyes with ocular hypertension that did not 
become glaucomatous over a 12-month follow-up period. Interestingly, they also noted that 
the changes in PPA observed in eyes with progressive glaucoma were both too small and too 
rare to explain the high prevalence and large size of PPA in eyes with glaucoma. They 
speculated that eyes with inherited large β-zone may be more susceptible to the development 
of glaucoma, a view later shared by Healey et al40 following their investigation on the 
inheritance of PPA. Tezel et al31 analyzed serial optic disc photographs of 350 OHT eyes 
with 10-year follow-up and observed PPA enlargement in 9.9% of non-progressive eyes and 
in 49% of eyes that eventually developed OAG. In another retrospective study19 performed 
in 75 glaucomatous eyes with PPA at baseline and a minimum follow-up of 4 years, 93% of 
the 28 eyes where progression of PPA was observed showed progressive optic disc damage 
Savatovsky et al. Page 7













or visual field loss. Budde and Jonas16 in a longitudinal large series of OAG, OHT, and 
normal eyes, described a progressive enlargement of PPA β-zone in 2.7% of glaucomatous 
eyes and in 0.3% of OHT eyes. In eyes with OAG, PPA β -zone enlargement was more 
frequently observed in eyes with progressive than those with stable glaucoma. On the 
contrary, after comparing both baseline and progression rates of PPA area and neuroretinal 
rim area measured with scanning confocal laser tomography every 6 months for 8.6 years in 
94 patients with OAG and 7.1 years in 54 normal control subjects, See et al4 reported similar 
baseline and follow-up PPA areas in the two groups. In addition, they found no correlation 
between rates of global PPA area and neuroretinal rim area progression both in both groups. 
Also in agreement with our findings, Quigley and colleagues5 did not find a significant 
difference in the prevalence of PPA between OHT patients who progressed and who did not 
progress to overt glaucoma after a 5-year follow up. Because the clinical value of PPA with 
regard to the diagnosis of OAG remains controversial, Ehrlich and Radcliffe41 used 
generalized linear models to determine if clinical PPA assessment improves the prediction 
of glaucoma hemifield test (GHT) beyond that of standard assessment of variables such as 
age, central corneal thickness, IOP and cup-to-disc ratio. The results indicated that adding 
PPA parameters to a model already containing these commonly assessed variables does not 
significantly improve the ability to discriminate between OAG and no glaucoma status.
The similar rates of PPA β-zone enlargement in converters and in non-converters found in 
our series of OHT subjects suggest a lack of relationship between increase in PPA β-zone 
area and development of glaucomatous damage. This discrepancy compared to the earlier 
studies described in the previous paragraph may be due to differences in study design (i.e. 
cross-sectional or longitudinal), follow-up length, sample size, border delineation methods 
(i.e. manual or automated), PPA size assessment (i.e. qualitative or quantitative), and 
definition of glaucoma progression. Our findings are based on manual planimetry performed 
by two independent, masked, and consistent readers on digitized optic disc stereoscopic 
photographs analyzed with a computerized measuring tool. In some eyes the PPA β-zone 
was large and easily detected, but in many others it was small with poorly definable borders, 
increasing the chance of being overlooked without the detailed evaluation and standardized 
delineation performed in this study. Surprisingly, none of the earlier studies has clearly 
acknowledged the difficulty associated with delineating PPA boundaries in some eyes, 
which has led to the wrong belief that outlining PPA boundaries is always relatively easy. 
With our thorough disc assessment and tracing technique we observed a mean 10% PPA β-
zone area enlargement on follow-up photographs in both cases and controls. Of the 28 eyes 
with quantitative PPA progression described by Uchida et al,19 7 (25%) were not detected 
by qualitative assessment by observers. The average increase in PPA area not detected by 
qualitative analysis was 8.2% versus quantitatively detectable increase of 18.3%. We also 
found diversity between groups in PPA α-zone measurements on follow-up, which we 
believe generated a difference in α-zone enlargement between cases and controls, and an 
apparent small reduction in α-zone area in non-converters. Interpretation of this finding is 
limited since PPA α-zone measurements had a less than optimal reproducibility, as in other 
studies.
As far as we know, we have studied the largest and longest prospectively collected series of 
optic disc photographs in OHT patients. Some variability in measurements is introduced by 
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manual delineation of optic disc and α- and β-zone margins on stereoscopic disc 
photographs, but it seems relatively small. New technologies such as computerized optic 
nerve head analyzers may provide more objective and even more consistent delineation of 
optic disc and PPA margins, and perhaps the ability to detect even smaller changes in the 
area of PPA more reliably. For example, spectral domain optical coherence tomography 
(SD-OCT) reconstructs “in vivo” three-dimensional optic disc and peripapillary structures 
by detecting termination of the various retinal layers.42-45 Lee et al42 used SD-OCT to 
evaluate the cross-sectional configuration of α and β-zones in 120 normal eyes, ., all of 
which showed an α-zone and 75% presented a β-zone on optic disc photographs. Specific 
OCT findings corresponding to α- and β-zone, respectively, were the gradual thinning of 
retinal layers immediately related to Bruch's membrane (inner segment-outer segment 
junction of the photoreceptors and the external limiting membrane) found in 87% of the 
eyes, and absence of the retinal pigment epithelial layer observed in 100% of the 90 eyes in 
which β-zone was visible. Kim et al43 analyzed the continuity of Bruch's membrane in 161 
OAG eyes presenting β-zone and observed intact Bruch's membrane in 76 eyes (47%). This 
group was significantly older compared to groups presenting discontinuous or absent 
Bruch's membrane, suggesting that PPA presenting an intact Bruch's membrane could be an 
age-related atrophic change, and that the pathogenesis of PPA may be diverse. We found an 
increase in PPA size over time in converters to OAG and controls, indicating that PPA 
enlargement may be due to other factors such as age. This observation corroborates the 
findings of histologic46 and SD-OCT studies.47
In conclusion, based on results of previous studies and the findings of our series, it seems 
that the value of measuring PPA size over time in subjects with OHT for the diagnosis of 
conversion to glaucoma is still uncertain. Although PPA is seen in patients with glaucoma, 
clinical decisions should not be based on the presence of and/or change in PPA alone. In 
OHT subjects, PPA enlargement may occur independently of glaucoma conversion, and 
systematically with time, suggesting that a substantial part of this phenomenon may be age-
related.
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Longitudinal measurement of peripapillary atrophy (PPA) size, particularly β-zone, is an 
unreliable mean for diagnosing the conversion of ocular hypertension to glaucoma 
because PPA may enlarge to the same degree in converters and non-converters.
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Left eye optic disc photographs of one of the study participants without (left) and with 
delineation of the disc in red, PPA α-zone in green, and PPA β-zone combined with scleral 
ring in blue. In this case, PPA α and β-zone margins coincide nasally.
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Bland-Altman plots of the difference (% of disc size) between the two readers against their 
averages. Inter-reader agreement on measurements of change in β-zone (A and B), α zone 
(C and D), and α + β zones (E and F). Plots on the left are for eyes with non-progressive 
OHT and plots on right are for eyes that converted to POAG.
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Differences between follow-up and baseline β-zone areas (% of disc size) in case and control 
eyes.
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Table 1
Participant Demographic and Ocular Characteristics at Baseline Visit
Progressive OHT (n = 279) Non-progressive OHT (n = 222) P Value
Mean age (±SD), years 58 (9) 58 (9) 0.99
Sex, male (%) 157 (56) 117 (53) 0.48
Mean spherical equivalent (±SD), D −0.56 (2.5) −0.37 (2.4) 0.36
OHT: ocular hypertension; SD: standard deviation, D: diopter
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Table 2
Between Reader Reproducibility of Optic Disc and Peripapillary Atrophy Areas Before and After Conversion 
to Percent of Disc Area
Pre-conversion ICC (95% CI) (in pixels) Post-conversion ICC (95% CI) (in % of disc area)
Optic disc 0.967 (0.86-0.99) N/A
β-zone 0.831 (0.67-0.90) 0.823 (0.77-0.86)
α-zone 0.582 (0.53-0.63) 0.483 (0.40-0.55)
CI: confidence intervals
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Table 3
Mean β-zone and α-zone Areas (as a percent of disc area) at Baseline, Follow-up, and Difference (follow-up 
minus baseline), in the glaucoma conversion and control groups.
Groups Mean B-zone area (±SD) Mean α-zone area (±SD)
Percentage of disc area st baseline Control 49.9 (24.3) 19.1





Percentage of disc area at follow-up Control 59.8 (48.3) 17.5 (13.4)





Follow-up minus baseline area as % of disc area Control 10.1 (33.7) −1.70 (21.0)
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